Literature DB >> 19117

Some observations on the mechanism of benzodiazepine-barbiturate interactions in the mouse.

D M Chambers, G C Jefferson.   

Abstract

1 The prolongation of pentobarbitone sleeping by five benzodiazepines, administered by prior intraperitoneal injection, was measured in mice. The pentobarbitone was injected either intraperitoneally or intracerebroventricularly. For each benzodiazepine, the prolongation was dose-related and differences in potency between benzodiazepines were not marked. 2 The percentage prolongation of sleeping times produced by most of the benzodiazepines was greater when the pentobarbitone was given intracerebroventricularly and was explained by a preferential addition of CNS depressant effects associated with this route. 3 To test whether the action of intraperitoneally administered pentobarbitone had been influenced by a metabolic component, the effects of nitrazepam on drug metabolism, measured by changes in plasma phenazone levels in the mouse, were studied. Nitrazepam (32 mg/kg, i.p.) produced a 23% reduction in the rate of phenazone metabolism. 4 Nitrazepam was also shown to have produced a transient fall in body temperature. Calculations based on Q10 values suggested that this hypothermia accounted, at most, for half the metabolic change measured.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 19117      PMCID: PMC1667302          DOI: 10.1111/j.1476-5381.1977.tb07514.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  Inhibition of drug metabolizing enzymes by diazepam in rat liver.

Authors:  M Vorne; J Idänpään-Heikkilä
Journal:  Experientia       Date:  1975-08-15

2.  Effects of chronic prazepam administration on drug metabolism in man and rat.

Authors:  E S Vesell; G T Passananti; J P Viau; J E Epps; F J Di Carlo
Journal:  Pharmacology       Date:  1972       Impact factor: 2.547

3.  The use of diazepam as premedication in pentobarbital anaesthesia in guinea-pigs.

Authors:  R Del Pozo; M C Armas
Journal:  Experientia       Date:  1973-05-15

4.  6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines which have central nervous system depressant activity.

Authors:  J B Hester; A D Rudzik; B V Kamdar
Journal:  J Med Chem       Date:  1971-11       Impact factor: 7.446

5.  Pharmacokinetics and dose-sleeping time lines of hexobarbital in mice.

Authors:  J Noordhoek
Journal:  Eur J Pharmacol       Date:  1968-06       Impact factor: 4.432

6.  The effect of reserpine, chlordiazepoxide and imipramine treatment on the potency of thiopental in man.

Authors:  T Tammisto; G Elfving; K Saikku; P Tiitinen
Journal:  Ann Chir Gynaecol Fenn       Date:  1967

7.  Metabolism and tolerance studies with chlordiazepoxide-2-l4C in the rat.

Authors:  D R Hoogland; T S Miya; W F Bousquet
Journal:  Toxicol Appl Pharmacol       Date:  1966-07       Impact factor: 4.219

8.  Failure of phenobarbitone to prevent febrile convulsions.

Authors:  J Z Heckmatt; A B Houston; D J Clow; J B Strephenson; K L Dodd; G T Lealman; R W Logan
Journal:  Br Med J       Date:  1976-03-06

9.  Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.

Authors:  E S Vesell; J G Page
Journal:  J Clin Invest       Date:  1969-12       Impact factor: 14.808

10.  The sensitivity of the brain to barbiturate during chronic administration and withdrawal of barbitone sodium in the rat.

Authors:  I H Stevenson; M J Turnbull
Journal:  Br J Pharmacol       Date:  1970-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.